資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://irlib.pccu.edu.tw/handle/987654321/48859
|
| 題名: | Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning |
| 作者: | Lai, YH (Lai, Yu-Heng)
Chen, WN (Chen, Wei-Ning)
Hsu, TC (Hsu, Te-Cheng)
Lin, C (Lin, Che)
Tsao, Y (Tsao, Yu)
Wu, SM (Wu, Semon) |
| 貢獻者: | 化學系 |
| 關鍵詞: | EXPRESSION
ADENOCARCINOMA
PROGNOSIS
CHEMOTHERAPY
ONCOGENES
PROTEINS
GENE
HUR |
| 日期: | 2020-12-01 |
| 上傳時間: | 2020-12-10 13:43:25 (UTC+8) |
| 摘要: | Non-small cell lung cancer (NSCLC) is one of the most common lung cancers worldwide. Accurate prognostic stratification of NSCLC can become an important clinical reference when designing therapeutic strategies for cancer patients. With this clinical application in mind, we developed a deep neural network (DNN) combining heterogeneous data sources of gene expression and clinical data to accurately predict the overall survival of NSCLC patients. Based on microarray data from a cohort set (614 patients), seven well-known NSCLC biomarkers were used to group patients into biomarker- and biomarker+ subgroups. Then, by using a systems biology approach, prognosis relevance values (PRV) were then calculated to select eight additional novel prognostic gene biomarkers. Finally, the combined 15 biomarkers along with clinical data were then used to develop an integrative DNN via bimodal learning to predict the 5-year survival status of NSCLC patients with tremendously high accuracy (AUC: 0.8163, accuracy: 75.44%). Using the capability of deep learning, we believe that our prediction can be a promising index that helps oncologists and physicians develop personalized therapy and build the foundation of precision medicine in the future. |
| 關聯: | SCIENTIFIC REPORTS 卷冊: 10 期: 1 文獻號碼: 4679 |
| 顯示於類別: | [化學系所] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 184 | 檢視/開啟 |
|
在CCUR中所有的資料項目都受到原著作權保護.
|
